Close Menu

NEW YORK – Exuma Biotech on Tuesday said it will collaborate with Moffitt Cancer Center to advance the development its point-of-care CAR T-cell product for B-cell malignancies.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.